• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痛风:全因和心血管死亡率的独立危险因素。

Gout: an independent risk factor for all-cause and cardiovascular mortality.

机构信息

Graduate Institute of Clinical Medical Sciences, Chang Gung University, Kwei-Shan Tao-Yuan, Taiwan.

出版信息

Rheumatology (Oxford). 2010 Jan;49(1):141-6. doi: 10.1093/rheumatology/kep364. Epub 2009 Nov 20.

DOI:10.1093/rheumatology/kep364
PMID:19933595
Abstract

OBJECTIVE

The relation of gout and hyperuricaemia to cardiovascular diseases has been well documented. This study investigates the survival impact of both gout and hyperuricaemia.

METHODS

The subjects of this study comprised participants of a health screening programme conducted by the Chang Gung Memorial Hospital in Taiwan from 2000 to 2006. The status and causes of death were ascertained by the Taiwan National Death Registry 2000-07. Cox proportional hazard model was performed to examine the association.

RESULTS

Among 61 527 subjects, 1383 deaths (198 cardiovascular deaths) were identified, corresponding to a crude mortality rate of 4.86 deaths per 1000 person-years. Crude mortality rates were 4.50, 5.61 and 10.46 deaths per 1000 person-years for subjects with normouricaemia, hyperuricaemia and gout, respectively. Compared with subjects with normouricaemia, the hazard ratios (HRs) of all-cause mortality were 1.46 (95% CI 1.12, 1.91) for individuals with gout and 1.07 (95% CI 0.94, 1.22) for those with hyperuricaemia, respectively, after adjustments were made for age, sex, component number of metabolic syndrome and proteinuria. The adjusted HRs of cardiovascular mortality were 1.97 (95% CI 1.08, 3.59) for individuals with gout and 1.08 (95% CI 0.78, 1.51) for those with hyperuricaemia. Moreover, the risk of all-cause or cardiovascular mortality for gout remained unchanged when limiting the data to those with an estimated glomerular filtration of >60 ml/min/1.73 m(2).

CONCLUSION

This study demonstrates a link of gout, not hyperuricaemia, with a higher risk of death from all causes and cardiovascular diseases.

摘要

目的

痛风和高尿酸血症与心血管疾病的关系已得到充分证实。本研究调查了痛风和高尿酸血症对生存的影响。

方法

本研究的对象为台湾长庚纪念医院 2000 年至 2006 年进行的健康筛查计划的参与者。2000-07 年台湾国家死亡登记处确定了死亡状况和原因。采用 Cox 比例风险模型进行相关性分析。

结果

在 61527 名受试者中,有 1383 人死亡(198 人死于心血管疾病),粗死亡率为每 1000 人年 4.86 人。血尿酸正常、高尿酸血症和痛风患者的粗死亡率分别为 4.50、5.61 和 10.46 人/1000 人年。校正年龄、性别、代谢综合征成分数和蛋白尿后,与血尿酸正常者相比,痛风患者全因死亡率的危险比(HR)分别为 1.46(95%可信区间 1.12,1.91),高尿酸血症患者的 HR 为 1.07(95%可信区间 0.94,1.22)。校正后痛风患者心血管死亡率的 HR 为 1.97(95%可信区间 1.08,3.59),高尿酸血症患者的 HR 为 1.08(95%可信区间 0.78,1.51)。此外,当将数据限制在估计肾小球滤过率>60ml/min/1.73m2 的患者时,痛风患者全因或心血管疾病死亡率的风险仍然不变。

结论

本研究表明,痛风与全因和心血管疾病死亡风险增加有关,而高尿酸血症则无此关联。

相似文献

1
Gout: an independent risk factor for all-cause and cardiovascular mortality.痛风:全因和心血管死亡率的独立危险因素。
Rheumatology (Oxford). 2010 Jan;49(1):141-6. doi: 10.1093/rheumatology/kep364. Epub 2009 Nov 20.
2
Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.血清尿酸水平作为全因、心血管和缺血性卒中死亡的独立危险因素:一项中国队列研究。
Arthritis Rheum. 2009 Feb 15;61(2):225-32. doi: 10.1002/art.24164.
3
Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.长期暴露于交通相关空气污染对荷兰呼吸道和心血管疾病死亡率的影响:荷兰长期队列空气污染研究(NLCS-AIR研究)
Res Rep Health Eff Inst. 2009 Mar(139):5-71; discussion 73-89.
4
Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan.台湾中年劳动人口的全因死亡率、心血管疾病死亡率及肾小球滤过率降低情况
Am J Kidney Dis. 2008 Dec;52(6):1051-60. doi: 10.1053/j.ajkd.2008.05.030. Epub 2008 Aug 15.
5
Long-term cardiovascular mortality among middle-aged men with gout.中年痛风男性的长期心血管死亡率
Arch Intern Med. 2008 May 26;168(10):1104-10. doi: 10.1001/archinte.168.10.1104.
6
Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality.痛风和高尿酸血症与全因和心血管死亡率的独立和联合关联。
QJM. 2013 Jul;106(7):647-58. doi: 10.1093/qjmed/hct083. Epub 2013 Apr 5.
7
Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality.血清尿酸水平对全因和心血管死亡率风险的意义。
Rheumatology (Oxford). 2013 Jan;52(1):127-34. doi: 10.1093/rheumatology/kes223. Epub 2012 Aug 25.
8
Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile.心血管疾病高危男性中痛风与2型糖尿病风险
Rheumatology (Oxford). 2008 Oct;47(10):1567-70. doi: 10.1093/rheumatology/ken305. Epub 2008 Aug 18.
9
Independent impact of gout on mortality and risk for coronary heart disease.痛风对死亡率和冠心病风险的独立影响。
Circulation. 2007 Aug 21;116(8):894-900. doi: 10.1161/CIRCULATIONAHA.107.703389. Epub 2007 Aug 13.
10
Hyperuricemia, gout, and cardiovascular disease--an important "muddle".高尿酸血症、痛风与心血管疾病——一个重要的“谜团”。
Bull NYU Hosp Jt Dis. 2009;67(3):285-90.

引用本文的文献

1
Group-based trajectory modeling to assess adherence to chronic urate-lowering therapies among commercially insured US adults with gout.基于群组的轨迹建模,用于评估美国商业保险的痛风成年患者对慢性降尿酸治疗的依从性。
J Manag Care Spec Pharm. 2025 Aug;31(8):795-807. doi: 10.18553/jmcp.2025.31.8.795.
2
Physiological serum uric acid concentrations correlate with arterial stiffness in a sex-dependent manner.生理血清尿酸浓度与动脉僵硬度存在性别依赖性关联。
BMC Med. 2025 Jul 1;23(1):356. doi: 10.1186/s12916-025-04195-8.
3
Current Challenges and Emerging Therapies in the Treatment of Gout.
痛风治疗中的当前挑战与新兴疗法
Curr Rheumatol Rev. 2025;21(3):239-251. doi: 10.2174/0115733971302054240627072809.
4
Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study.美国虚拟人群中痛风合并慢性肾脏病的预期健康和经济负担:一项微观模拟研究
Rheumatol Ther. 2024 Aug;11(4):913-926. doi: 10.1007/s40744-024-00681-2. Epub 2024 Jun 5.
5
Review: The Role of Dual-Energy Computed Tomography in Detecting Monosodium Urate Deposits in Vascular Tissues.综述:双能 CT 在检测血管组织中单钠尿酸盐沉积中的作用。
Curr Rheumatol Rep. 2024 Aug;26(8):302-310. doi: 10.1007/s11926-024-01151-y. Epub 2024 May 13.
6
Major cardiovascular events in patients with cardiovascular monosodium urate deposits in atherosclerotic plaques.动脉粥样硬化斑块中存在心血管尿酸钠沉积的患者的主要心血管事件
Rheumatology (Oxford). 2025 Mar 1;64(3):1443-1447. doi: 10.1093/rheumatology/keae240.
7
The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout.钠-葡萄糖共转运蛋白 2 抑制剂在痛风患者中的临床获益。
Nat Rev Rheumatol. 2024 Apr;20(4):216-231. doi: 10.1038/s41584-024-01092-x. Epub 2024 Mar 12.
8
Detection of monosodium urate depositions and atherosclerotic plaques in the cardiovascular system by dual-energy computed tomography.通过双能计算机断层扫描检测心血管系统中的尿酸钠沉积和动脉粥样硬化斑块。
Heliyon. 2024 Jan 17;10(2):e24548. doi: 10.1016/j.heliyon.2024.e24548. eCollection 2024 Jan 30.
9
Impact of gout on cardiovascular disease mortality: a meta-analysis.痛风对心血管疾病死亡率的影响:一项荟萃分析。
Z Rheumatol. 2024 Dec;83(Suppl 3):329-337. doi: 10.1007/s00393-024-01479-x. Epub 2024 Feb 1.
10
Unclosing Premature Mortality Gap Among Patients With Gout in the US General Population, Independent of Serum Urate and Atherosclerotic Cardiovascular Risk Factors.消除美国普通人群中痛风患者过早死亡差距,独立于血清尿酸和动脉粥样硬化心血管危险因素。
Arthritis Care Res (Hoboken). 2024 May;76(5):691-702. doi: 10.1002/acr.25292. Epub 2024 Feb 14.